Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
197.47B
Market cap197.47B
Price-Earnings ratio
10.74
Price-Earnings ratio10.74
Dividend yield
2.69%
Dividend yield2.69%
Average volume
18.15M
Average volume18.15M
High today
$45.46
High today$45.46
Low today
$44.39
Low today$44.39
Open price
$45.40
Open price$45.40
Volume
8.71M
Volume8.71M
52 Week high
$81.44
52 Week high$81.44
52 Week low
$35.12
52 Week low$35.12

NVO News

Nasdaq 1h
Buy, Sell, or Hold Novo Nordisk at $46?

Key Points The bulk of Novo Nordisk's sales come from weight-loss and diabetes treatments. The biotech faces competition from companies like Eli Lilly and Pfi...

Buy, Sell, or Hold Novo Nordisk at $46?
Simply Wall St 14h
Novo Nordisk Valuation Check After Mixed Year To Date And 1 Year Share Returns

Advertisement Recent share performance and business profile Novo Nordisk (NYSE:NVO) has drawn investor attention after a mixed stretch for the stock, with the...

Novo Nordisk Valuation Check After Mixed Year To Date And 1 Year Share Returns
Nasdaq 21h
Best Healthcare Stocks to Buy in 2026

Key Points Biogen will likely benefit from increased sales of its Alzheimer's therapy, Leqembi. Both companies have been active in acquisitions. Novo Nordisk...

Best Healthcare Stocks to Buy in 2026

Analyst ratings

58%

of 36 ratings
Buy
33.3%
Hold
58.3%
Sell
8.3%

More NVO News

The Motley Fool 1d
Should Eli Lilly Investors Worry About Its Newest Rival -- From Within?

Eli Lilly (LLY +2.61%) has become the leader in a market marching toward the $100 billion mark. I'm talking about the weight-loss drug market, expected to reach...

Should Eli Lilly Investors Worry About Its Newest Rival -- From Within?
Simply Wall St 2d
Novo Nordisk Oral Wegovy Data Sharpen Obesity Opportunity And Valuation Gap

Novo Nordisk (NYSE:NVO) released detailed Phase 3 OASIS 4 and STEP UP data for its oral Wegovy obesity treatment. The new results highlight sustained weight lo...

Novo Nordisk Oral Wegovy Data Sharpen Obesity Opportunity And Valuation Gap
Seeking Alpha 2d
Novo Nordisk added as a new long idea at Hedgeye

Novo Nordisk (NVO) was added as a new long idea with the potential for 52% to 117% upside. "At $46, the Street is mispricing a $50M-patient US TAM, a duopoly t...

Novo Nordisk added as a new long idea at Hedgeye
Nasdaq 2d
Is Novo Nordisk's Rebound for Real--or Just a Head Fake?

Key Points Novo Nordisk recently posted strong quarterly results. Newer launches are boosting sales. Novo Nordisk has a strong pipeline of assets in its core...

Is Novo Nordisk's Rebound for Real--or Just a Head Fake?
Benzinga 2d
Novo Nordisk Highlights New Wegovy Pill Data

The company said adults treated with oral semaglutide 25 mg achieved clinically meaningful weight loss regardless of whether they experienced rapid early reduct...

Novo Nordisk Highlights New Wegovy Pill Data
TipRanks 2d
Novo Nordisk Discloses Gifted Share Transactions Linked to CFO Associates

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Nasdaq 2d
Novo Nordisk A/S Q1 Earnings Call Highlights

Novo Nordisk A/S (NYSE:NVO) said its first quarter of 2026 was marked by rapid uptake of its newly launched Wegovy pill in the U.S., continued expansion of its...

Novo Nordisk A/S Q1 Earnings Call Highlights

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.